Header Logo

Connection

IVAN CHINN to Janus Kinases

Back to Details
This is a "connection" page, showing publications IVAN CHINN has written about Janus Kinases.
IVAN CHINN
Connection Strength
0.037
Janus Kinases
  1. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018 06; 141(6):2142-2155.e5.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.